'Artificial Pancreas' for Diabetics with Dangerous Blood Sugar Levels
Katie Cordrey — February 7, 2010 — Lifestyle
An ‘Artificial Pancreas’ system using pumps and monitors to improve blood sugar control in diabetes patients has been tested in a medical trial by researchers from Britain’s Cambridge University and shown to keep blood sugar levels within the normal range 60% of the time.
Children with Type 1 diabetes were given a matchbox-sized monitor and a like-sized pump fitted with a tube to deliver insulin into the body. The device was able to stabilize blood sugar and reduce the amount of time that blood sugar remained at a dangerous level by half.
Children with Type 1 diabetes were given a matchbox-sized monitor and a like-sized pump fitted with a tube to deliver insulin into the body. The device was able to stabilize blood sugar and reduce the amount of time that blood sugar remained at a dangerous level by half.
Trend Themes
-
Artificial Pancreas System — The development of an artificial pancreas system using pumps and monitors presents an opportunity for disruptive innovation in the healthcare industry.
-
Improved Blood Sugar Control — The advancement in technologies for improving blood sugar control offers opportunities for disruptive innovation in the medical devices industry.
-
Personalized Diabetes Management — The implementation of personalized diabetes management solutions opens up disruptive innovation opportunities in the healthcare sector.
Industry Implications
-
Healthcare — The healthcare industry can benefit from disruptive innovation by integrating artificial pancreas systems for better diabetes management.
-
Medical Devices — The medical devices industry has the potential to disrupt the market by developing and commercializing advanced technologies for blood sugar control.
-
Health Technology — The health technology sector can leverage personalized diabetes management solutions as a disruptive innovation to revolutionize patient care.
3.7
Score
Popularity
Activity
Freshness
